Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Creative Medical Technology Holdings (CELZ) Revenue (2017 - 2025)

Creative Medical Technology Holdings has reported Revenue over the past 9 years, most recently at $3000.0 for Q4 2025.

  • Quarterly Revenue changed 0.0% to $3000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6000.0 through Dec 2025, down 45.45% year-over-year, with the annual reading at $6000.0 for FY2025, 45.45% down from the prior year.
  • Revenue was $3000.0 for Q4 2025 at Creative Medical Technology Holdings, roughly flat from $3000.0 in the prior quarter.
  • Over five years, Revenue peaked at $67754.0 in Q4 2021 and troughed at $3000.0 in Q4 2023.
  • The 5-year median for Revenue is $9000.0 (2021), against an average of $16862.8.
  • Biggest five-year swings in Revenue: skyrocketed 450.0% in 2022 and later tumbled 89.09% in 2023.
  • Tracing CELZ's Revenue over 5 years: stood at $67754.0 in 2021, then tumbled by 72.55% to $18600.0 in 2022, then crashed by 83.87% to $3000.0 in 2023, then changed by 0.0% to $3000.0 in 2024, then changed by 0.0% to $3000.0 in 2025.
  • According to Business Quant data, Revenue over the past three periods came in at $3000.0, $3000.0, and $3000.0 for Q4 2025, Q1 2025, and Q4 2024 respectively.